NCT06021366View on ClinicalTrials.gov

Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study

CompletedOBSERVATIONAL
Enrollment

2,089

Participants

Timeline

Start Date

January 7, 2022

Primary Completion Date

August 29, 2022

Study Completion Date

August 29, 2022

Conditions
Neovascular Age-related Macular Degeneration
Trial Locations (1)

2740-255

Novartis, Porto Salvo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY